Richard J. Hirschman
- Hematology top 5%
- Platelet Disorders and Treatments 5
- Hemophilia Treatment and Research 3
-
- Lymphoma Diagnosis and Treatment 2
-
- Polyomavirus and related diseases 2
- Viral-associated cancers and disorders 2
-
- Viral gastroenteritis research and epidemiology 1
- SARS-CoV-2 and COVID-19 Research 1
-
- Blood properties and coagulation 1
- Co-authors
- N. Raphael ShulmanHarvey R. GralnickBarry S. CollerSamuel B. ItscoitzCraig E. MetrokaSushil K. JainArthur F. GoldbergElizabeth D. Ames
- Cited by
- HematologyGeneticsHepatology
- Partner nations
- United StatesSweden
In The Last Decade
Richard J. Hirschman
15 papers receiving 394 citations
Peers
Comparison fields: 5 of 72
- Hematology 198
- Genetics 60
- Hepatology 38
- Pathology and Forensic Medicine 76
- Obstetrics and Gynecology 25
Countries citing papers authored by Richard J. Hirschman
This map shows the geographic impact of Richard J. Hirschman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard J. Hirschman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard J. Hirschman more than expected).
Fields of papers citing papers by Richard J. Hirschman
This network shows the impact of papers produced by Richard J. Hirschman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard J. Hirschman. The network helps show where Richard J. Hirschman may publish in the future.
Co-authorship network
The 16 scholars most cited alongside Richard J. Hirschman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1991 | 54 | |
| 2 | Endometrial carcinoma in five patients with breast cancer on tamoxifen therapy. | 1990 | 32 |
| 3 | 1985 | 8 | |
| 4 | 1983 | 28 | |
| 5 | 1975 | 42 | |
| 6 | 1975 | 1 | |
| 7 | A simplified platelet factor 3 (PF-3) assay for the rapid detection of platelet isoantibodies and an antiplatelet factor in ATP and SLE. | 1974 | 19 |
| 8 | 1973 | 109 | |
| 9 | 1973 | 24 | |
| 10 | 1972 | 3 | |
| 11 | 1970 | 30 | |
| 12 | 1969 | 39 | |
| 13 | 1969 | 62 | |
| 14 | 1965 | 5 | |
| 15 | 1965 | 5 |
About Richard J. Hirschman
Richard J. Hirschman is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine, having authored 15 papers that have together received 461 indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (5 papers), Hemophilia Treatment and Research (3 papers), Polyomavirus and related diseases (2 papers), Viral-associated cancers and disorders (2 papers), Lymphoma Diagnosis and Treatment (2 papers), Viral gastroenteritis research and epidemiology (1 paper), Blood properties and coagulation (1 paper) and SARS-CoV-2 and COVID-19 Research (1 paper). The work is most often cited by research in Hematology (198 citations), Genetics (60 citations) and Hepatology (38 citations). Richard J. Hirschman has collaborated with scholars based in United States and Sweden. Frequent co-authors include N. Raphael Shulman, Harvey R. Gralnick, Barry S. Coller, Samuel B. Itscoitz, Craig E. Metroka, Sushil K. Jain, Arthur F. Goldberg, Elizabeth D. Ames, B Kabakow and Ada B. Chabon. Their work appears in journals such as Annals of Internal Medicine, Thrombosis Research, Cancer, British Journal of Haematology and Hematology/Oncology Clinics of North America.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.